Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-22
1994-10-18
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514866, A61K 3144, A61K 31425
Patent
active
053569130
ABSTRACT:
The present invention provides a method for treating hypertension in insulin resistant patients comprising the administration of an insulin sensitizing agent, particularly ciglitazone or pioglitazone.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4687777 (1987-08-01), Meguro et al.
patent: 5053420 (1991-10-01), Pershadsingh
Chang, A. Y. et al., "Ciglitazone, a New Hypoglycemic Agent: II. Effect on Glucose and Lipid Metabolisms and Insulin Binding in the Adipose Tissue of C57BL/6J-ob/ob and -+/? Mice", Diabetes, vol. 32, No. 9, Sep. 1983, pp. 839-845.
Chang, A. Y. et al., "Ciglitazone, A New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats", Diabetes, vol. 32, No. 9, Sep. 1983, pp. 830-838.
Cintins Marianne M.
Criares T. J.
The Upjohn Company
Welch Lawrence T.
LandOfFree
Use of insulin sensitizing agents to treat hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin sensitizing agents to treat hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin sensitizing agents to treat hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372762